OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 42
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
The Role of SWI /SNF Complex in Bladder Cancer
Zhenlain Lei, Yanfeng Han, John B. Liao, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
Zhenlain Lei, Yanfeng Han, John B. Liao, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy
Zhecheng Yu, Zheng–Yi Zhou, Yunqi Zhao
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 293-308
Open Access
Zhecheng Yu, Zheng–Yi Zhou, Yunqi Zhao
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 293-308
Open Access
Gene–Environment Interaction: Small Deletions (DELs) and Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) and Potential Implications for Therapy
Farzana Jasmine, Armando Almazan, Yuliia Khamkevych, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 95-95
Open Access
Farzana Jasmine, Armando Almazan, Yuliia Khamkevych, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 95-95
Open Access
Biomimetic Diselenide‐Sonosensitizer Nanoplatform for Enhanced Sonodynamic Therapy and In Situ Remodeling Immunosuppressive Microenvironment via Activating Innate and Adaptive Immunotherapy
Yifan Xue, Qingliang Wang, Y. Eugene Chen, et al.
Advanced Healthcare Materials (2025)
Closed Access
Yifan Xue, Qingliang Wang, Y. Eugene Chen, et al.
Advanced Healthcare Materials (2025)
Closed Access
New insights into the ferroptosis and immune infiltration in endometriosis: a bioinformatics-based analysis
Lusha Liu, Feifei Han, Naiyi Du, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Lusha Liu, Feifei Han, Naiyi Du, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access
The Role of UBR2 in Triple-Negative Breast Cancer and Its Implications for Immune Checkpoint Blockade Therapy
Yanlin Jiang, Yi Fu, Xinyan Song, et al.
(2025)
Closed Access
Yanlin Jiang, Yi Fu, Xinyan Song, et al.
(2025)
Closed Access
The Efficacy of Curcumin in Reducing Immunosuppressive States of Peripheral Blood Mononuclear Cells Extracted From Oral Squamous Cell Carcinoma Patients: An In Vitro Study
Prakruti Dash, Saurav Nayak, Pradipta Kumar Parida
Cureus (2025)
Open Access
Prakruti Dash, Saurav Nayak, Pradipta Kumar Parida
Cureus (2025)
Open Access
HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model
Toshihiro Yamaguchi, Shuji Kitahara, Aya Matsui, et al.
Medical Molecular Morphology (2025)
Closed Access
Toshihiro Yamaguchi, Shuji Kitahara, Aya Matsui, et al.
Medical Molecular Morphology (2025)
Closed Access
Identification of PIF1 as a Ferroptosis-Related Prognostic Biomarker Correlated with Immune Infiltration in Hepatocellular Carcinoma
Feng Liu, Ping Yin, Lifang Lu, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Feng Liu, Ping Yin, Lifang Lu, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Based on the immune system: the role of the IL-2 family in pancreatic disease
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T‐Cells Infiltration and Immunosuppression
Xiangyuan Luo, Wenjie Huang, Siwen Li, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Xiangyuan Luo, Wenjie Huang, Siwen Li, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 3
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 3
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 3
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 3
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review
Yanzhu Qin, S Lu, Jingwen Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Yanzhu Qin, S Lu, Jingwen Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Current and Future Perspectives of PDL1 PET and SPECT Imaging
Indraja D. Dev, Ameya Puranik, Baljinder Singh, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 6, pp. 966-975
Open Access | Times Cited: 1
Indraja D. Dev, Ameya Puranik, Baljinder Singh, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 6, pp. 966-975
Open Access | Times Cited: 1
Role of UFMylation in tumorigenesis and cancer immunotherapy
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
PD-L1 DNA aptamers isolated from agarose-bead SELEX
Muhammad Najmi Mohd Nazri, Nur Amira Khairil Anwar, Nur Fatihah Mohd Zaidi, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129943-129943
Closed Access
Muhammad Najmi Mohd Nazri, Nur Amira Khairil Anwar, Nur Fatihah Mohd Zaidi, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129943-129943
Closed Access
Bioengineered extracellular vesicles presenting PD-L1 and Gal-9 to ameliorate new-onset primary ovarian insufficiency (POI)
Guannan Zhou, Yuanyuan Gu, Jingxin Ding, et al.
Research Square (Research Square) (2024)
Open Access
Guannan Zhou, Yuanyuan Gu, Jingxin Ding, et al.
Research Square (Research Square) (2024)
Open Access
An evaluation of durvalumab across the spectrum of urothelial carcinoma
Ek Leone Oh, Andrew Redfern, Dickon Hayne
Expert Review of Anticancer Therapy (2024)
Closed Access
Ek Leone Oh, Andrew Redfern, Dickon Hayne
Expert Review of Anticancer Therapy (2024)
Closed Access
Limitations and potential strategies of immune checkpoint blockade in age-related neurodegenerative disorders
Noha N. Lasheen, Salma Allam, Abdullrahman Elgarawany, et al.
The Journal of Physiological Sciences (2024) Vol. 74, Iss. 1
Open Access
Noha N. Lasheen, Salma Allam, Abdullrahman Elgarawany, et al.
The Journal of Physiological Sciences (2024) Vol. 74, Iss. 1
Open Access